B7-33 

B7-33  is a synthetic peptide engineered as a single-chain analog of the human hormone relaxin-2. Researchers designed B7-33 to selectively activate the Relaxin Family Peptide Receptor 1 (RXFP1), making it an important research tool for investigating receptor pharmacology, peptide signaling, and cellular communication. Its receptor-selective profile has positioned B7-33 as a valuable compound in advanced peptide research and molecular biology,B7-33 6mg Peptide.

Scientific investigations have utilized B7-33 to explore RXFP1-mediated signaling pathways involved in extracellular matrix regulation, tissue biology, cellular homeostasis, and peptide-receptor interactions. Researchers continue to examine its molecular characteristics to better understand the biological mechanisms associated with relaxin signaling and receptor activation under controlled laboratory conditions. These studies contribute to ongoing research in peptide pharmacology, biotechnology, and regenerative biology, B7-33 6mg Peptide.

Manufacturers formulate B7-33 (6mg) as a high-purity, research-grade lyophilized peptide suitable for academic, pharmaceutical, and biotechnology laboratories. Every production batch undergoes comprehensive analytical testing to verify identity, purity, and batch-to-batch consistency, helping researchers achieve reliable and reproducible experimental results. The lyophilized presentation supports long-term stability and allows accurate preparation for validated laboratory protocols.

Product Information

• Product Name: B7-33
• Strength: 6mg per vial
• Peptide Class: Synthetic relaxin-2 analog
• Primary Target: Relaxin Family Peptide Receptor 1 (RXFP1)
• Appearance: White to off-white lyophilized powder
• Grade: Research grade
• Purity: High purity (Certificate of Analysis available for applicable batches)
• Intended Use: Laboratory research only

Research Applications

Researchers commonly investigate B7-33 (6mg) in studies involving:

• RXFP1 receptor signaling
• Relaxin peptide biology
• Peptide-receptor interaction analysis
• Cellular signaling pathways
• Extracellular matrix research
• Molecular and cellular biology
• Biotechnology and pharmaceutical research
• Experimental peptide pharmacology

Quality Assurance

Every batch of B7-33 passes rigorous quality control and analytical verification to confirm identity, purity, and consistency before release. Strict manufacturing standards support dependable performance across advanced laboratory research applications and promote reproducible scientific investigations.

Storage

Store the lyophilized peptide in a cool, dry laboratory environment away from moisture, heat, and direct light. After reconstitution, follow established laboratory storage procedures to maintain peptide stability and sample integrity.

Disclaimer

B7-33 (6mg) is supplied exclusively for scientific and laboratory research purposes. This product is not intended for human consumption, veterinary use, clinical applications, therapeutic treatment, or diagnostic procedures. Qualified laboratory personnel should handle this peptide in accordance with established laboratory protocols, institutional guidelines, and all applicable regulations.